Diabetes is a key risk factor for kidney disease, which is one of the leading causes of death in the United States and worldwide; about 1 in 3 people with diabetes also has chronic kidney disease, according to the US Centers for Disease Control and Prevention.
But new research shows that weekly injections of semaglutide cut the risk of severe outcomes from diabetic kidney disease by about 24%.
The new study found even broader related benefits of semaglutide treatment among people with diabetic kidney disease.
“Kidney disease attributed to diabetes, or diabetic kidney disease, is one of the most common and deadly complications of diabetes.
Yet, unfortunately, there’s very low awareness around it,” said Dr. Katherine Tuttle, chair of the Diabetic Kidney Disease Collaborative for the American Society of Nephrology.
Persons:
”, Vlado Perkovic, “ Semaglutide, Martin Holst Lange, Katherine Tuttle, ” It’s, Tuttle, semaglutide, It’s, Dr, Sanjay Gupta, White, ” Tuttle
Organizations:
CNN, Diabetes, US Centers for Disease Control, New England, of Medicine, European Renal Association Congress, University of New, University of New South Wales Sydney, Novo Nordisk, American Society of Nephrology, Providence Inland Northwest Health, Health Sciences, University of Washington, CNN Health
Locations:
United States, University of New South, Danish, American